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Drug companies withholding 
information on trial protocols
A study published in the Journal of the Royal Society of Medicine 
shows that half of commercially sponsored trial protocols contain 
redactions, meaning that drug companies are withholding information 
on trial protocols. The authors of the study requested access to 78 
commercial and non-commercial trial protocols approved by a 
research ethics committee in Denmark from October 2012 to March 
2013, under freedom of information rules. However, they found that 
access was difficult despite their assurances that individual trials 
would not be identified. It took 3 years to receive all 79 protocols, 
and Sanofi-Aventis took legal action. Other companies that withheld 
information included Merck Sharp & Dohme, Novo Nordisk, Bayer 
and GlaxoSmithKline. Only three companies supplied unredacted 
protocols – Abbott, Pfizer and Eli Lilly.
Eight of the protocols were excluded from the final results, showing 
that 17 of 34 protocols for commercially sponsored trials were not 
redacted, compared with 34 of 36 non-commercial trials. The protocol 
information most likely to be withheld was evidence of problems with 
the reliability of the data, such as data analysis, handling of missing data, 
detection and analysis of adverse events and premature termination of 
the study. The authors could not identify any legitimate rationale for 
the redactions, and commented that the amount of redactions in the 
protocols received was so large that they were rendered useless for 
assessing the ethical justification for the studies and for identifying 
discrepancies with subsequent publications.
Marquardsen M, Ogden M, Gøtzsche P. Redactions in protocols for drug trials: What industry sponsors 
concealed. J R Soc Med 2018 (epub 25 January 2018). https://doi.org/10.1177/0141076817750554
Drinking very hot tea linked to 
oesophageal cancer
Regularly drinking very hot tea, when combined with tobacco or 
alcohol use, is associated with an increased risk of oesophageal 
cancer, according to a Chinese study with more than 450 000 
participants. However, the study, published in  Annals of Internal 
Medicine, found no increased risk of oesophageal cancer in those who 
drank hot tea but did not smoke or regularly drink alcohol. Alcohol 
consumption and tobacco smoking are already well-established 
causes of oesophageal squamous cell cancer.
The prospective study included 456 155 people aged between 30 
and 79 years from 10 areas across China. The participants in the study 
were asked how often they drank tea and whether they drank it warm, 
hot or boiling hot. They were also asked about smoking habits and 
whether they drank 15 g of alcohol or more a day – roughly two units, 
or a standard glass of wine.
During a median follow-up of 9.2 years there were 1 731 new 
cases of oesophageal cancer. Individuals who drank tea at a 
high temperature, drank alcohol regularly and smoked had an 
oesophageal cancer risk five times greater than those who had 
none of those three habits. The risk of oesophageal cancer was also 
increased for those who drank hot or burning hot tea if they either 
smoked or drank excessively.
Yu C, Tang H, Guo Y, et al. Effect of hot tea consumption and its interactions with alcohol and tobacco use 
on the risk of esophageal cancer: A population based cohort study. Ann Intern Med 2018 (epub 6 February 
2018). https://doi.org/10.7326/M17-2000
Alcohol more dangerous to the brain 
than marijuana
Scientists at the University of Colorado Boulder conducted a review 
of existing imaging data that looked at the effects of alcohol and 
marijuana, or cannabis, on the brain. Their findings linked alcohol 
consumption with long-term changes to the structure of white matter 
and grey matter in the brain. However, the use of marijuana seemed 
to have no significant long-term effects on brain structure.
Study leader Rachel Thayer, of the Department of Psychology and 
Neuroscience at the University of Colorado Boulder, and colleagues 
recently reported their results in the journal Addiction.
Thayer RE, YorkWilliams S, Karoly HC, et al. Structural neuroimaging correlates of alcohol and cannabis use 
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